Phase I-II Study HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer With or Without Metastatic Disease
Latest Information Update: 03 May 2022
At a glance
- Drugs Aglatimagene besadenovec (Primary) ; Valaciclovir (Primary)
- Indications Prostate cancer
- Focus Adverse reactions
- 29 Jun 2016 Status changed from active, no longer recruiting to recruiting.
- 16 Mar 2016 Status changed from recruiting to active, no longer recruiting, according to ClinicalTrials.gov record.
- 22 Aug 2013 New trial record